Long-term outcome of treatment with ruxolitinib in myelofibrosis

Ayalew Tefferi; Mark R. Litzow; Animesh Pardanani

doi:10.1056/NEJMc1109555

Long-term outcome of treatment with ruxolitinib in myelofibrosis

Hematology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1455-1457
Number of pages	3
Journal	New England Journal of Medicine
Volume	365
Issue number	15
DOIs	https://doi.org/10.1056/NEJMc1109555
State	Published - Oct 13 2011

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc1109555

Cite this

@article{6c5336cc7bdd4baaac035c078da48341,

title = "Long-term outcome of treatment with ruxolitinib in myelofibrosis",

author = "Ayalew Tefferi and Litzow, \{Mark R.\} and Animesh Pardanani",

year = "2011",

month = oct,

day = "13",

doi = "10.1056/NEJMc1109555",

language = "English (US)",

volume = "365",

pages = "1455--1457",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "15",

}

TY - JOUR

T1 - Long-term outcome of treatment with ruxolitinib in myelofibrosis

AU - Tefferi, Ayalew

AU - Litzow, Mark R.

AU - Pardanani, Animesh

PY - 2011/10/13

Y1 - 2011/10/13

UR - https://www.scopus.com/pages/publications/80054028202

UR - https://www.scopus.com/pages/publications/80054028202#tab=citedBy

U2 - 10.1056/NEJMc1109555

DO - 10.1056/NEJMc1109555

M3 - Letter

C2 - 21995409

AN - SCOPUS:80054028202

SN - 0028-4793

VL - 365

SP - 1455

EP - 1457

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 15

ER -

Long-term outcome of treatment with ruxolitinib in myelofibrosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this